I-Track: Enhanced Surveillance of HIV, Hepatitis C and Associated Risk Behaviours Among People Who Inject Drugs in Canada: Phase 2 Report
This report presents descriptive findings from I-Track Phase 2 surveys conducted between June 1, 2005, and November 28, 2008, at participating sentinel sites in Canada. The results provide a comprehensive overview from a national perspective and are intended to inform human immunodeficiency virus (HIV) prevention and control efforts, public health policy development, and program evaluation. The results provide a baseline which can provide the context for more complex analyses which have been and/or will be performed.
This publication can be made available in alternative formats upon request. Please contact email@example.com
|Published by:||Public Health Agency of Canada (PHAC)|
|Specific Population(s):||People who use injection drugs|
|Access:||Download the PDF|